US 11191758
Use of selective serotonin 5-HT1A receptor agonists for treating side-effects of VMAT inhibitors
granted A61KA61K31/135A61K31/428
Quick answer
US patent 11191758 (Use of selective serotonin 5-HT1A receptor agonists for treating side-effects of VMAT inhibitors) held by Uniwersytet Jagiellonski Collegium Medicum expires Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Uniwersytet Jagiellonski Collegium Medicum
- Grant date
- Tue Dec 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/135, A61K31/428, A61K31/435, A61K31/4418